Eastern Capital LTD

Eastern Capital LTD has an estimated net worth of $354 Million. This is based on reported shares across multiple companies, which include AASTROM BIOSCIENCES INC, PEREGRINE PHARMACEUTICALS INC, CYTOKINETICS INC, Cyclacel Pharmaceuticals, Inc., iBio, Inc., and TAPIMMUNE INC.

2016 was Eastern Capital LTD's most active year for acquiring shares with 6 total transactions. Eastern Capital LTD's most active month to acquire stocks was the month of April. 2020 was Eastern Capital LTD's most active year for disposing of shares, totalling 9 transactions. Eastern Capital LTD's most active month to dispose stocks was the month of July. 2020 saw Eastern Capital LTD paying a total of $6,285,000.40 for 29,341,667 shares, this is the most they've acquired in one year. In 2020 Eastern Capital LTD cashed out on 29,592,160 shares for a total of $98,166,409.01, their largest year based on trade value.